Skip to content
ACETAdicet Bio, Inc.

Earnings

When Adicet Bio, Inc. reports, what it reported each quarter, and how the stock took the results.

39 quarters. Mar 31, 2017 to Sep 30, 2026. mixed units.

Next results · Q4 2026Projected

Mar 11, after the close

Thu, Mar 11, 2027in 114 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Mar 9 – 19

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
—
Net income
-$30.52M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026-$18.88MNo Q3 2025 on file

Latest results

  1. Q3 2026Nov 5, 2026, after the closeThe release+2.2%by the close of Nov 6
    Revenue
    —
    —
    Net income
    -$18.88M
    N/M
    EPS
    -$1.76
    N/M
    On November 5, 2026, Adicet Bio, Inc. announced its financial results for the quarter ended September 30, 2026.
  2. Q2 2026Aug 5, 2026, after the closeThe release13.1%by the close of Aug 6
    Revenue
    —
    —
    Net income
    -$21.36M
    N/M
    EPS
    -$1.99
    N/M
  3. Q1 2026May 13, 2026, after the closeThe release+5.2%by the close of May 14
    Revenue
    —
    —
    Net income
    -$20.24M
    N/M
    EPS
    -$1.88
    N/M
  4. Q4 2025Mar 12, 2026, after the closeThe release+1.1%by the close of Mar 13
    Revenue
    —
    —
    Net income
    -$30.52M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 5, 2026 · after-hoursNov 5, 202636 d10-Q——-$1.76+2.2%
Q2 2026Jun 30, 2026Aug 5, 2026 · after-hoursAug 5, 202636 d10-Q——-$1.9913.1%
Q1 2026Mar 31, 2026May 13, 2026 · after-hoursMay 13, 202643 d10-Q——-$1.88+5.2%
FY 2025
Q4 2025derivedDec 31, 2025Mar 12, 2026 · after-hoursMar 12, 202671 d10-K———+1.1%
Q3 2025Sep 30, 2025Nov 5, 2025 · after-hoursNov 5, 202536 d10-Q——-$4.723.4%
Q2 2025Jun 30, 2025Aug 7, 2025 · after-hoursAug 7, 202538 d10-Q——-$5.488.7%
Q1 2025Mar 31, 2025May 6, 2025 · after-hoursMay 6, 202536 d10-Q——-$4.9617.4%
FY 2024
Q4 2024derivedDec 31, 2024Mar 6, 2025 · after-hoursMar 6, 202565 d10-K———2.8%
Q3 2024Sep 30, 2024Nov 6, 2024 · after-hoursNov 6, 202437 d10-Q——-$0.34+4.7%
Q2 2024Jun 30, 2024Aug 13, 2024 · pre-marketAug 13, 202444 d10-Q——-$0.33—
Q1 2024Mar 31, 2024May 14, 2024 · after-hoursMay 14, 202444 d10-Q——-$0.35—
Earlier years, FY 2017 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 5, 2026000066
10-QAug 5, 2026000050
10-QMay 13, 2026000037
10-KMar 12, 2026000008
10-QNov 5, 2025266880
10-QAug 7, 2025104978
10-QMay 6, 2025064448
10-KMar 6, 2025034587
10-QNov 6, 2024122253
10-QAug 13, 2024095745

Provenance

ProvenanceData status and checks

Adicet Bio, Inc. · CIK 1720580 · Engraved from SEC EDGAR